2 bold stock market ideas to consider for a Stocks and Shares ISA
Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...
Vertex Pharmaceuticals’ (VRTX) “Outperform” Rating Reaffirmed at William Blair
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at ...
BBC18d
Aviation accidents and incidents
Three people were hurt when the private plane crashed on to the driveway of an East Yorkshire home. The last four minutes of data before the disaster which killed 179 people are missing, transport ...
The Motley Fool25d
Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip
Vertex Pharmaceuticals is trying to diversify its product portfolio. One of the programs it's working on aims to treat pain in a few contexts. There's reason to believe that it won't be effective ...
Philippine Daily Inquirer25d
Aboitiz, Ang and airports: Billionaires bet on aviation boom
Build and they will come. Billionaires Sabin Aboitiz and Ramon Ang are keen on making the Philippines more accessible to tourists who are big spenders when vacationing here, a country known for ...
FiercePharma27d
Vertex snags FDA nod for once-daily cystic fibrosis triplet Alyftrek as switch from Trikafta kicks off
As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...
BioSpace28d
Vertex Wins FDA Approval for New Cystic Fibrosis Option but Stock Still Down
It’s welcome good news for Vertex following last week’s subpar clinical results for its non-opioid analgesic. Vertex Pharmaceuticals said Friday the FDA has approved its next cystic fibrosis product ...
The Motley Fool29d
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?
Vertex Pharmaceuticals stock was heading for a double-digit gain this year until recent weeks. The company is approaching an important turning point -- one that could set the tone for revenue ...
Business Wire1mon
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...